Literature DB >> 21726211

CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.

T S L Keesen1, L R V Antonelli, D R Faria, L H Guimarães, O Bacellar, E M Carvalho, W O Dutra, K J Gollob.   

Abstract

Leishmaniasis is caused by infection with the protozoan parasite, Leishmania, that parasitizes human cells, and the cellular immune response is essential for controlling infection. In order to measure the host T cell response to Leishmania infection, we have measured the expansion, activation state and functional potential of specific T cells as identified by their T cell receptor Vβ region expression. In a group of cutaneous leishmaniasis (CL) patients, we evaluated these characteristics in nine different T cell subpopulations as identified by their Vβ region expression, before and after specific Leishmania antigen stimulation. Our results show: (1) an increase in CD4(+) T cells expressing Vβ 5·2 and Vβ 24 in CL compared to controls; (2) a Leishmania antigen-induced increase in CD4(+) T cells expressing Vβ 5·2, 11, 12 and 17; (3) a profile of previous activation of CD4(+) Vβ 5·2-, 11- and 24-positive T cells, with higher expression of CD45RO, HLA-DR, interferon-γ, tumour necrosis factor-α and interleukin-10 compared to other Vβ-expressing subpopulations; (4) a positive correlation between higher frequencies of CD4(+) Vβ5·2(+) T cells and larger lesions; and (5) biased homing of CD4(+) T cells expressing Vβ 5·2 to the lesion site. Given that CL disease involves a level of pathology (ulcerated lesions) and is often followed by long-lived protection and cure, the identification of specific subpopulations active in this form of disease could allow for the discovery of immunodominant Leishmania antigens important for triggering efficient host responses against the parasite, or identify cell populations most involved in pathology.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726211      PMCID: PMC3170983          DOI: 10.1111/j.1365-2249.2011.04430.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  [Evaluation of the sensitization power of Montenegro skin test].

Authors:  F F José; I M da Silva; M I Araújo; R P Almeida; O Bacellar; E M Carvalho
Journal:  Rev Soc Bras Med Trop       Date:  2001 Nov-Dec       Impact factor: 1.581

Review 3.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

Review 4.  Type 1 and type 2 responses to Leishmania major.

Authors:  Kathleen A Rogers; Gregory K DeKrey; M Lamine Mbow; R Dean Gillespie; Claudia I Brodskyn; Richard G Titus
Journal:  FEMS Microbiol Lett       Date:  2002-03-19       Impact factor: 2.742

5.  Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Authors:  R L Bottrel; W O Dutra; F A Martins; B Gontijo; E Carvalho; M Barral-Netto; A Barral; R P Almeida; W Mayrink; R Locksley; K J Gollob
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells.

Authors:  R P Costa; K J Gollob; L L Fonseca; M O Rocha; A C Chaves; N Medrano-Mercado; T C Araújo-Jorge; P R Antas; D G Colley; R Correa-Oliveira; G Gazzinelli; J Carvalho-Parra; W O Dutra
Journal:  Scand J Immunol       Date:  2000-05       Impact factor: 3.487

Review 7.  Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.

Authors:  Hiro Goto; José Angelo Lauletta Lindoso
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

8.  Antigen triggering selectively increases TCRBV gene transcription.

Authors:  G P Lennon; J E Sillibourne; E Furrie; M J Doherty; R A Kay
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

9.  Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites.

Authors:  Jorge Clarêncio; Camila I de Oliveira; Glória Bomfim; Margarida M Pompeu; Maria Jania Teixeira; Theolis C Barbosa; Sebastião Souza-Neto; Edgar M Carvalho; Cláudia Brodskyn; Aldina Barral; Manoel Barral-Netto
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

10.  Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?

Authors:  A Gomes-Silva; R de Cássia Bittar; R Dos Santos Nogueira; V S Amato; M da Silva Mattos; M P Oliveira-Neto; S G Coutinho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

View more
  14 in total

1.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size.

Authors:  É L M Vieira; T S L Keesen; P R Machado; L H Guimarães; E M Carvalho; W O Dutra; K J Gollob
Journal:  Parasite Immunol       Date:  2013-02       Impact factor: 2.280

3.  Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Authors:  Sara Passos; Lucas P Carvalho; Rúbia S Costa; Taís M Campos; Fernanda O Novais; Andréa Magalhães; Paulo R L Machado; Daniel Beiting; David Mosser; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

Review 4.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

5.  High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Carlos Oscar S Sorzano; Mariano Esteban
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

6.  The immunobiology of Leishmania braziliensis infection.

Authors:  Camila I de Oliveira; Claudia I Brodskyn
Journal:  Front Immunol       Date:  2012-06-08       Impact factor: 7.561

7.  T-cell receptor Vβ repertoire of CD8+ T-lymphocyte subpopulations in cutaneous leishmaniasis patients from the state of Rio de Janeiro, Brazil.

Authors:  Raquel Ferraz; Clarissa Ferreira Cunha; Maria Inês Pimentel; Marcelo Rosandiski Lyra; Armando Oliveira Schubach; Sérgio Coutinho Furtado de Mendonça; Alda Maria Da-Cruz; Alvaro Luiz Bertho
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-24       Impact factor: 2.743

8.  Proteome profiling of human cutaneous leishmaniasis lesion.

Authors:  Claire da Silva Santos; Sanaz Attarha; Ravi Kanth Saini; Viviane Boaventura; Jackson Costa; Ricardo Khouri; Manoel Barral-Netto; Cláudia Ida Brodskyn; Serhiy Souchelnytskyi
Journal:  J Invest Dermatol       Date:  2014-09-10       Impact factor: 8.551

9.  Paracoccidioides brasiliensis infection promotes thymic disarrangement and premature egress of mature lymphocytes expressing prohibitive TCRs.

Authors:  Rosaria Di Gangi; Thiago Alves da Costa; Rodolfo Thomé; Gabriela Peron; Eva Burger; Liana Verinaud
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

Review 10.  Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection.

Authors:  Patrícia Sampaio Tavares Veras; Juliana Perrone Bezerra de Menezes
Journal:  Int J Mol Sci       Date:  2016-08-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.